Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction. 2020

Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
Immunoallergology Unit, Department of Medicine and Geriatrics, Careggi University Hospital, Florence, Italy.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody

Related Publications

Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
October 2021, Clinical lymphoma, myeloma & leukemia,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
May 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
September 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
July 2022, Journal of hepatology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
January 2015, Journal of investigational allergology & clinical immunology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
January 2021, Journal of the European Academy of Dermatology and Venereology : JEADV,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
December 2012, Pituitary,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
July 2021, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
July 1998, Toxicological sciences : an official journal of the Society of Toxicology,
Alessandra Vultaggio, and Francesca Nencini, and Susanna Bormioli, and Laura Dies, and Emanuele Vivarelli, and Enrico Maggi, and Andrea Matucci
December 2022, Iranian journal of immunology : IJI,
Copied contents to your clipboard!